4-methylthioamphetamine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 12 studies
| Studies (4-methylthioamphetamine) | Trials (4-methylthioamphetamine) | Recent Studies (post-2010) (4-methylthioamphetamine) | Studies (n-methyl-3,4-methylenedioxyamphetamine) | Trials (n-methyl-3,4-methylenedioxyamphetamine) | Recent Studies (post-2010) (n-methyl-3,4-methylenedioxyamphetamine) |
|---|---|---|---|---|---|
| 38 | 0 | 9 | 4,276 | 211 | 1,392 |
| Protein | Taxonomy | 4-methylthioamphetamine (IC50) | n-methyl-3,4-methylenedioxyamphetamine (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.9351 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.1761 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 1.06 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.7609 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, SG; Cloonan, SM; Corrigan, D; Jørgensen, AM; Keating, JJ; Knox, AJ; Lloyd, DG; Meegan, MJ; Peters, GH; Rai, D; Williams, DC | 1 |
| Cloonan, SM; Corrigan, D; Kavanagh, PV; Keating, JJ; Meegan, MJ; O'Brien, JE; Williams, DC | 1 |
| Butler, SG; Cloonan, SM; Keating, JJ; Knox, AJ; McNamara, YM; Meegan, MJ; Peters, GH; Williams, DC | 1 |
| Elliott, SP | 1 |
| Baird, AW; Cannon, DM; Flynn, JJ; Guiry, PJ; Keenan, AK; McBean, GJ; McCormack, P; Murphy, J | 1 |
| Ceglia, I; Gobbi, M; Mennini, T; Moia, M; Pirona, L; Reyes-Parada, M; Scorza, C | 1 |
| Guiry, PJ; Keenan, AK; McBean, GJ; Quinn, ST; Schwab, T | 1 |
| Bastos, ML; Carvalho, F; Custódio, JB; Fernandes, E; Fernandes, MA; Gonçalves, DI; Moreno, AJ; Santos, MS; Vicente, JA | 1 |
| Nichols, D | 1 |
| Carmo, H; Dias da Silva, D; Silva, E | 1 |
| Carmo, H; da Silva, DD; Silva, E | 1 |
| Aoki, Y; Ishiba, A; Kato, H; Maeno, Y; Matsumoto, T; Monma-Ohtaki, J; Nagao, M; Seko-Nakamura, Y | 1 |
12 other study(ies) available for 4-methylthioamphetamine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Topics: Amphetamines; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Phenethylamines; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfur | 2009 |
Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.
Topics: Amphetamines; Cell Line; Cell Line, Tumor; Cells, Cultured; Humans; Methamphetamine; Neurons; Phenethylamines; Sulfur | 2010 |
Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents.
Topics: Alkenes; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Drug Design; Humans; Molecular Structure; Nitro Compounds; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2011 |
Analysis of 4-methylthioamphetamine in clinical specimens.
Topics: Amphetamines; Animals; Chromatography, High Pressure Liquid; Hallucinogens; Humans; Indicators and Reagents; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Spectrophotometry, Ultraviolet; Substance-Related Disorders | 2001 |
In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine.
Topics: Amphetamines; Animals; Brain; Muscle, Smooth, Vascular; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptosomes | 2002 |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
Topics: Amphetamines; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nerve Tissue Proteins; p-Chloroamphetamine; Piperazines; Rats; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Tritium | 2002 |
Blockade of noradrenaline transport abolishes 4-methylthioamphetamine-induced contraction of the rat aorta in vitro.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Aorta, Thoracic; Biological Transport; Brain; Dose-Response Relationship, Drug; Fluoxetine; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Rats; Rats, Wistar; Synaptosomes; Tritium; Vasoconstriction | 2006 |
Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function.
Topics: Adrenergic Uptake Inhibitors; Amphetamines; Animals; Energy Metabolism; Hallucinogens; Hepatocytes; Hydrogen Peroxide; In Vitro Techniques; Male; Membrane Potentials; Mitochondria, Liver; Mitochondrial Membranes; N-Methyl-3,4-methylenedioxyamphetamine; Oxygen Consumption; Rats; Rats, Wistar; Sulfhydryl Compounds | 2010 |
Legal highs: the dark side of medicinal chemistry.
Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease; Research Personnel; Schizophrenia; Substance-Related Disorders | 2011 |
The risky cocktail: what combination effects can we expect between ecstasy and other amphetamines?
Topics: Amphetamines; Cell Line; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Humans; Illicit Drugs; Methamphetamine; Models, Theoretical; N-Methyl-3,4-methylenedioxyamphetamine; Regression Analysis | 2013 |
Combination effects of amphetamines under hyperthermia - the role played by oxidative stress.
Topics: Adenosine Triphosphate; Amphetamines; Cell Survival; Dextroamphetamine; Dose-Response Relationship, Drug; Energy Metabolism; Glutathione; Hep G2 Cells; Hepatocytes; Humans; Hyperthermia, Induced; Lipid Peroxidation; Methamphetamine; Mitochondria, Liver; Mitochondrial Membranes; N-Methyl-3,4-methylenedioxyamphetamine; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Risk Assessment | 2014 |
5-hydroxytryptamine- and dopamine-releasing effects of ring-substituted amphetamines on rat brain: a comparative study using in vivo microdialysis.
Topics: Amphetamines; Animals; Brain; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Dopamine; Extracellular Fluid; Hydroxyindoleacetic Acid; Inhibitory Concentration 50; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin; Time Factors | 2014 |